Prot #NU 16H07: Phase II Trial of Pembrolizumab in Combination with ICE Salvage Chemotherapy for Relapsed/Refractory Hodgkin Lymphoma

Project: Research project

StatusActive
Effective start/end date4/3/174/3/20

Funding

  • Merck Sharp & Dohme Corp. (Prot #NU 16H07)